title: Acute Stroke and Transient Ischemic Attack in the Outpatient Clinic.
abstract: Ischemic stroke is cause of substantial death and disability in the United States. Transient ischemic attack, a precursor to ischemic stroke, conveys a high risk of recurrent stroke within 90 days from event. These conditions are highly preventable and treatable. The cause is heterogenous and includes atherothrombosis, cardioembolism, lacunar disease, or cryptogenic, and some uncommon causes, such as arterial dissection and prothrombotic states. The emergent evaluation includes establishing time of onset, vital signs, glucose level, and severity of the deficit.
authors.affiliation: Department of Neurology, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, 4800 Alberta Avenue, Room 108, El Paso, TX 79905, USA. Electronic address: Salvador.cruz-flores@ttuhsc.edu.
authors.forename: Salvador
authors.initials: S
authors.lastname: Cruz-Flores
mesh_terms: D000367:Age Factors; D000554:Ambulatory Care Facilities; D001786:Blood Glucose; D001794:Blood Pressure; D015897:Comorbidity; D003937:Diagnosis, Differential; D004630:Emergencies; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D019934:International Normalized Ratio; D002546:Ischemic Attack, Transient / Q000175:diagnosis / Q000188:drug therapy* / Q000628:therapy*; D010102:Oxygen Inhalation Therapy; D018570:Risk Assessment; D012307:Risk Factors; D055502:Secondary Prevention / Q000379:methods; D020521:Stroke / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy*; D017131:Thrombectomy / Q000379:methods; D013997:Time Factors
chemical_list: D001786:Blood Glucose; D005343:Fibrinolytic Agents
keywords: Emergent evaluation; Risk stratification; Stroke; TIA; Transient ischemic attack; Treatment